Nasol, Baby Boy .

HRN: 23-43-35  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/31/2023
AMPICILLIN 250MG (VIAL)
07/31/2023
08/07/2023
IVTT
115mg
Q12
PSNB
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: